These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9635211)

  • 21. Striatal structure and function in mood disorders: a comprehensive review.
    Marchand WR; Yurgelun-Todd D
    Bipolar Disord; 2010 Dec; 12(8):764-85. PubMed ID: 21176024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
    Lyoo IK; Renshaw PF
    Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of psychiatric diseases: current status and future prospects.
    Kalia M; Costa E Silva J
    Metabolism; 2015 Mar; 64(3 Suppl 1):S11-5. PubMed ID: 25467847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory quantum resonance spectrometer as a discriminator for psychiatric affective disorders.
    Zhang Y; Liu F; Shi J; Yue X; Zhang H; Du X; Sun L; Yuan J
    J Nerv Ment Dis; 2014 Apr; 202(4):287-91. PubMed ID: 24647211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional brain imaging in neuropsychiatric disorders of childhood.
    O'Tuama LA; Dickstein DP; Neeper R; Gascon GG
    J Child Neurol; 1999 Apr; 14(4):207-21. PubMed ID: 10334394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].
    Pezard L; Nandrino JL
    Encephale; 2001; 27(3):260-8. PubMed ID: 11488256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies.
    Stuart MJ; Baune BT
    Neurosci Biobehav Rev; 2014 May; 42():93-115. PubMed ID: 24513303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adverse cognitive effects and ECT].
    Prapotnik M; Pycha R; Nemes C; König P; Hausmann A; Conca A
    Wien Med Wochenschr; 2006 Apr; 156(7-8):200-8. PubMed ID: 16823537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of catatonia in schizophrenia and mood disorders].
    van den Ameele S; Sabbe B; Morrens M
    Tijdschr Psychiatr; 2015; 57(2):94-8. PubMed ID: 25669945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Schedule for Affective Disorders and Schizophrenia (SADS)].
    Endicott J; Spitzer RL
    Acta Psychiatr Belg; 1987; 87(4):361-516. PubMed ID: 3434318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia.
    Belzeaux R; Boyer L; Ibrahim EC; Féron F; Leboyer M; Fond G
    Psychiatry Res; 2015 Sep; 229(1-2):613-6. PubMed ID: 26027439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates.
    Lieberman JA; Jody D; Alvir JM; Ashtari M; Levy DL; Bogerts B; Degreef G; Mayerhoff DI; Cooper T
    Arch Gen Psychiatry; 1993 May; 50(5):357-68. PubMed ID: 8489325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological indices in schizo-affective disorders].
    Souetre E; Robert P; Darcourt G
    Encephale; 1987; 13(5):309-16. PubMed ID: 2827994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schedule of Affective Disorders and Schizophrenia, a diagnostic interview in evaluations of insanity: an exploratory study.
    Rogers R; Cavanaugh JL; Dolmetsch R
    Psychol Rep; 1981 Aug; 49(1):135-8. PubMed ID: 7291407
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging genetics of mood disorders.
    Scharinger C; Rabl U; Sitte HH; Pezawas L
    Neuroimage; 2010 Nov; 53(3):810-21. PubMed ID: 20156570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Persistent depression with minute schizophrenia-like symptoms--from the viewpoint of "pluridimensional psychiatry"].
    Tanaka S
    Seishin Shinkeigaku Zasshi; 2014; 116(1):15-45. PubMed ID: 24640550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.
    Elkis H; Friedman L; Wise A; Meltzer HY
    Arch Gen Psychiatry; 1995 Sep; 52(9):735-46. PubMed ID: 7654125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mood disorders and the menstrual cycle.
    Rubinow DR; Schmidt PJ
    J Reprod Med; 1987 Jun; 32(6):389-94. PubMed ID: 3302247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating anti-brain autoantibodies in schizophrenia and mood disorders.
    Margari F; Petruzzelli MG; Mianulli R; Campa MG; Pastore A; Tampoia M
    Psychiatry Res; 2015 Dec; 230(2):704-8. PubMed ID: 26548982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.